You are here

  • Home
  • Archive
  • Volume 72, Issue Suppl 3
  • FRI0227 Acpa fine specificity is associated with increased plasmablast numbers and worse clinical response to rituximab in rheumatoid arthritis

Citation Tools

Article menu
Download PDFPDF
Poster Presentation
Rheumatoid arthritis - other biologic treatment
FRI0227 Acpa fine specificity is associated with increased plasmablast numbers and worse clinical response to rituximab in rheumatoid arthritis

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Vital EM, Israelsson L, Nogueira L, et al
FRI0227 Acpa fine specificity is associated with increased plasmablast numbers and worse clinical response to rituximab in rheumatoid arthritis
Annals of the Rheumatic Diseases 2013;72:A450.